Related content

New therapies for familial hypercholesterolemia

By Burnett John R   Watts Gerald F  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 349-361

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Familial Hypercholesterolemia

By  

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2575-2591

Bentham Science Publishers

Access to resources Recommend Favorite

Colesevelam: In Pediatric Patients with Heterozygous Familial Hypercholesterolemia

By Perry Caroline M.  

Pediatric Drugs, Vol. 12, Iss. 2, 2010-04 ,pp. : 133-140

Adis International

Access to resources Recommend Favorite

Defining the Role of Lipoprotein Apheresis in the Management of Familial Hypercholesterolemia

By >   Datta Borunendra N.   >   Rees Alan   Halcox Julian  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 363-370

Adis International

Access to resources Recommend Favorite

Predicting non-adherence in patients with familial hypercholesterolemia

By Galema-Boers J.   Lenzen M.   Domburg R.   Roeters van Lennep J.   Bruchem-van de Scheur G.   Sijbrands E.   Langendonk J.  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 391-397

Springer Publishing Company

Access to resources Recommend Favorite